Collegium Pharmaceutical Inc (COLL)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael Thomas Heffernan
Employees:
266
780 DEDHAM STREET, SUITE 800, CANTON, MA 02021
781-713-3699

Collegium Pharmaceutical, Inc. is a clinical-stage pharmaceutical company, which focuses on the development of proprietary, late stage pharmaceutical products. These products target market opportunities through formulation based product improvements protected by intellectual property. It builds a portfolio of pain products that incorporate its patent protected DETERx formulation platform that provides for extended release and tamper resistance. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Canton, MA.

Data derived from most recent annual or quarterly report
Market Cap 612.212 Million Shares Outstanding34.569 Million Avg 30-day Volume 166.112 Thousand
P/E Ratio23.246 Dividend Yield0.0 EPS2.51
Price to Revenue3.0368 Debt to Equity1.6761 EBITDA149.209 Million
Price to Book Value5.737 Operating Margin22.5271 Enterprise Value1.078 Billion
Current Ratio1.287 EPS Growth4.053 Quick Ratio1.199
1 Yr BETA 0.4898 52-week High/Low 26.91 / 17.22 Profit Margin13.0637
Operating Cash Flow Growth308.2505 Altman Z-Score1.5427 Free Cash Flow to Firm 110.771 Million
View SEC Filings from COLL instead.

View recent insider trading info

Funds Holding COLL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding COLL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

5.7 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DREYER SCOTT EVP & CHIEF COMMERCIAL OFFICER

  • Officer
76,269 2022-01-10 4

CIAFFONI JOSEPH PRESIDENT AND CEO

  • Officer
  • Director
263,904 2022-01-03 6

KUHLMANN SHIRLEY R. EVP AND GENERAL COUNSEL

  • Officer
89,256 2021-09-16 4

FLEMING ALISON B EVP & CHIEF TECHNICAL OFFICER

  • Officer
143,694 2021-08-10 4

TUPPER COLLEEN EVP & CHIEF FINANCIAL OFFICER

  • Officer
42,000 2021-05-24 2

BOHLIN GAREN G

  • Director
20,948 2021-05-20 1

SANTINI GINO

  • Director
44,136 2021-05-20 1

FREUND JOHN GORDON

  • Director
64,361 2021-05-20 1

HEFFERNAN MICHAEL THOMAS

  • Director
13,988 2021-05-20 2

FALLON JOHN A.

  • Director
23,323 2021-05-20 1

MELINCOFF GWEN A

  • Director
20,948 2021-05-20 1

BALICE-GORDON RITA J.

  • Director
14,968 2021-05-20 1

MALAMUT RICHARD EVP AND CHIEF MEDICAL OFFICER

  • Officer
93,558 2021-04-01 2

BRANNELLY PAUL EXECUTIVE VICE PRESIDENT & CFO

  • Officer
215,428 2021-02-10 1

SCHROEDER THEODORE R

  • Director
11,007 2020-05-20 0

HIRSCH DAVID

  • Director
21,164 2020-05-20 0

LONGITUDE CAPITAL PARTNERS, LLC

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

LONGITUDE CAPITAL ASSOCIATES, L.P.

LONGITUDE VENTURE PARTNERS L.P.

  • 10% Owner
No longer subject to file 2017-12-08 0

KANEKO YASUNORI

  • 10% Owner
2,150,186 2017-12-05 0

SKYLINE VENTURE PARTNERS V LP

SKYLINE VENTURE MANAGEMENT V, LLC

  • 10% Owner
2,149,916 2017-12-05 0

DUKE BARRY S SEE REMARKS

  • Officer
20,087 2017-03-17 0

NADAV ERAN

  • Director
0 2016-06-09 0

HERON PATRICK J

  • Director
  • 10% Owner
0 2015-09-10 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2015-05-12 0

FRAZIER HEALTHCARE VI, L.P.

FHM VI, L.P.

FHM VI, L.L.C.

FRAZIER ALAN D

NAINI NADER J

TOPPER JAMES N

EVERY NATHAN R

  • 10% Owner
No longer subject to file 2015-05-12 0

SKYLINE VENTURE PARTNERS V LP

SKYLINE VENTURE MANAGEMENT V, LLC

KANEKO YASUNORI

  • 10% Owner
2,949,916 2015-05-12 0

KOPECKY ERNEST A SEE REMARKS

  • Officer
0 2015-05-06 0

SAIM SAID VP, PHARMACEUTICAL DEVLP.

  • Officer
0 2015-05-06 0

CARLSON DOUGLAS R VP CORP. DEVLP

  • Officer
0 2015-05-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DREYER SCOTT - Officer EVP & CHIEF COMMERCIAL OFFICER

2022-01-12 16:22:23 -0500 2022-01-10 F 701 $19.05 d 76,269 direct 2.2051 -2.3705 2.2051 2 -3.3076 5

CIAFFONI JOSEPH - Director - Officer PRESIDENT AND CEO

2022-01-05 16:06:02 -0500 2022-01-03 F 1,090 $18.68 d 263,904 direct 0.4705 -5.1751 0.4705 2 -5.1751 6

DREYER SCOTT - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-12-17 16:33:22 -0500 2021-12-15 S 5,693 $18.33 d 76,970 direct -0.5832 4.4008 5.5143 5 -0.5832 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 22:15:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 21:45:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 21:15:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 20:45:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 20:15:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 19:45:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 19:15:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 18:45:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 18:15:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 17:45:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 17:15:03 UTC -0.2218 0.2918 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 16:45:03 UTC -0.2984 0.3684 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 16:15:03 UTC -0.2984 0.3684 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 15:45:03 UTC -0.2984 0.3684 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 15:15:03 UTC -0.2984 0.3684 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 14:45:03 UTC -0.2984 0.3684 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 14:15:03 UTC -0.2984 0.3684 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 13:45:03 UTC -0.2984 0.3684 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 13:15:03 UTC -0.2984 0.3684 550000
COLLEGIUM PHARMACEUTICAL INC COLL 2022-01-21 12:45:03 UTC -0.2984 0.3684 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Index Plus All-Cap Fund COLL -2.0 shares, $-32.66 2020-03-31 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund COLL -22990.0 shares, $-471984.7 2021-08-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund COLL -27944.0 shares, $-551614.56 2021-09-30 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio COLL -8206.0 shares, $-161986.44 2021-09-30 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund COLL -84000.0 shares, $-1648920.0 2021-10-31 N-PORT

Elevate your investments